# Feasibility and impact of pharmacist-led penicillin allergy delabelling using the PEN-FAST scoring tool in a Canadian tertiary care hospital

**Authors:** Claire Kamaliddin, Amanda Driver, Rebecca Druken, Elissa Rennert-May, Irina Rajakumar

PMC · DOI: 10.1017/ash.2026.10297 · Antimicrobial Stewardship & Healthcare Epidemiology : ASHE · 2026-02-16

## TL;DR

Pharmacists can safely remove incorrect penicillin allergy labels using a new tool called PEN-FAST, helping more patients receive effective antibiotics.

## Contribution

This study demonstrates the feasibility of pharmacist-led penicillin allergy delabeling using the PEN-FAST scoring tool in a Canadian hospital.

## Key findings

- Most of the 155 screened patients had their penicillin allergy label removed based on medical history.
- Twenty-nine patients were eligible for an oral challenge, and three successfully underwent the challenge.
- Pharmacists can effectively implement PEN-FAST scoring and oral challenges for delabeling.

## Abstract

Penicillins are the most frequently prescribed antibiotics for a broad range of infections. In North America, up to 15% of hospitalized patients report a penicillin allergy, but research has shown that 98% of these patients can tolerate penicillins. Removing inaccurate allergy labels is an essential component of antimicrobial stewardship. While allergy delabelling used to be complex or require an allergist referral, the emergence of new tools, such as the PEN-FAST score, facilitates direct delabeling of low-risk patients.

The primary objective of this study was to trial the use of the PEN-FAST scoring tool at a major tertiary care center in Canada. Secondary objectives included measuring the pharmacy workload associated with the delabeling process.

A prospective pilot study was implemented at a Canadian tertiary care hospital to identify new patients with a penicillin allergy label, perform a review of their medical history, obtain a PEN-FAST score, and if applicable, implement an oral challenge with amoxicillin.

Most of the 155 screened patients were delabeled based on their medical history. Twenty-nine patients were eligible for an oral challenge, and three challenges were conducted.

PEN-FAST scoring in combination with direct oral challenge is a practical tool that can be prospectively implemented by pharmacists.

## Linked entities

- **Chemicals:** amoxicillin (PubChem CID 33613)

## Full-text entities

- **Genes:** IGHE (immunoglobulin heavy constant epsilon) [NCBI Gene 3497] {aka IgE}, PCSK1N (proprotein convertase subtilisin/kexin type 1 inhibitor) [NCBI Gene 27344] {aka BigLEN, PEN, PROSAAS, SAAS, SCG8, SgVIII}, FASTK (Fas activated serine/threonine kinase) [NCBI Gene 10922] {aka FAST}
- **Diseases:** gastrointestinal symptoms (MESH:D012817), headache (MESH:D006261), penicillin (MESH:D008586), rash (MESH:D005076), cutaneous eruption (MESH:D003875), infection (MESH:D007239), allergies (MESH:D004342)
- **Chemicals:** diphenhydramine (MESH:D004155), epinephrine (MESH:D004837), amoxicillin (MESH:D000658), Penicillins (MESH:D010406)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12912928/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12912928/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12912928/full.md

---
Source: https://tomesphere.com/paper/PMC12912928